Cargando…
Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome()
People with Down syndrome (DS) develop Alzheimer's disease (AD) at higher rates and a younger age of onset compared to the general population. As the average lifespan of people with DS is increasing, AD is becoming an important health concern in this group. Neuroimaging is becoming an increasin...
Autores principales: | Neale, Natalie, Padilla, Concepcion, Fonseca, Luciana Mascarenhas, Holland, Tony, Zaman, Shahid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683343/ https://www.ncbi.nlm.nih.gov/pubmed/29159043 http://dx.doi.org/10.1016/j.nicl.2017.10.022 |
Ejemplares similares
-
Multi-Modal Imaging in Down's Syndrome: Maximizing Utility Through Innovative Neuroimaging Approaches
por: Brown, Stephanie S. G., et al.
Publicado: (2021) -
Alzheimer’s disease in people with Down’s syndrome: the prospects for and the challenges of developing preventative treatments
por: Castro, Paula, et al.
Publicado: (2016) -
Establishing diagnostic thresholds for Alzheimer's disease in adults with Down syndrome: the Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and Others with Intellectual Disabilities (CAMDEX-DS)
por: Beresford-Webb, Jessica A., et al.
Publicado: (2021) -
Neuroimaging Modalities in Alzheimer’s Disease: Diagnosis and Clinical Features
por: Kim, JunHyun, et al.
Publicado: (2022) -
Neuroimaging assessment in Down syndrome: a pictorial review
por: Rodrigues, Marta, et al.
Publicado: (2019)